Tesla
TSLA
Microsoft
MSFT
Oracle
ORCL
Alphabet-A
GOOGL
Ecopetrol
EC
US Stock MarketDetailed Quotes
SLN Silence Therapeutics
- 5.000
- +0.070+1.42%
Close Feb 19 16:00 ET
- 5.000
- 0.0000.00%
Post 16:05 ET
236.07MMarket Cap-2.95P/E (TTM)
5.160High4.750Low226.81KVolume4.920Open4.930Pre Close1.13MTurnover0.92%Turnover RatioLossP/E (Static)47.21MShares27.72052wk High1.98P/B123.32MFloat Cap4.06052wk Low--Dividend TTM24.66MShs Float35.000Historical High--Div YieldTTM8.32%Amplitude4.060Historical Low4.992Avg Price1Lot Size
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Silence Therapeutics Stock Forum
Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting
Silence Therapeutics presented additional Phase 1 results for divesiran in polycythemia vera (PV) patients at the ASH Annual Meeting. The SANRECO study data showed substantial reduction in phlebotomy frequency and lower hematocrit levels in 19 PV patients. Following treatment, only five phlebotomies were required during t...
$Rezolve AI (RZLV.US)$ Alot of short shares sold this month and in September. Reversal should be starting now that it has reached $1.63. First climb will be to 4.70 with that PT being at the end of December. February's PT will be 12.00. Partnerships with Microsoft and Google will push it until they re...
No comment yet